| CASE REPORT |
|
| Year : 2022 | Volume
: 5
| Issue : 1 | Page : 35-40 |
|
|
Case report on treatment of Karuppai Naarthasai Kattigal (uterine fibroids) with Rasagandhi Mezhugu
Annie Jasmine Swapna1, George Suseela Lekha1, Shyamala Rajkumar2
1 Department of Clinical Research, Siddha Regional Research Institute (CCRS), Poojapura, Thiruvananthapuram, Kerala, India
2 Department of Clinical Research, Siddha Regional Research Institute (CCRS), Puducherry, India
Correspondence Address:
Dr. Annie Jasmine Swapna
Siddha Regional Research Institute, Poojapura, Thiruvananthapuram - 695 012, Kerala
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jrsm.jrsm_18_22
|
|
|
Karuppai Naarthasai Kattigal (uterine fibroids) are benign tumors arising from the smooth muscles of the uterus. This study focuses over a case report of a patient with Karuppai Naarthasai Kattigal (uterine fibroids) treated with a classical Siddha drug, Rasagandhi Mezhugu (RGM) from the literature reference Pulippani Vaithiyam-500, for a period of 90 days, after receiving the informed consent, and the outcome was documented. A 40-year-old woman with a heavy menstrual bleeding, frequent urination, abdominal cramps, and bloating of abdomen often for 6 months and intermenstrual bleeding for 2 years was screened through an ultrasonogram, suspecting uterine fibroids. After Siddha clinical assessment and diagnosis, RGM was administered for a period of 90 days with 15 days drug holiday after 45 days of treatment. Later the treatment outcomes were measured and the patient is followed up for 6 months. This study reveals the outcome of the treatment of Karuppai Naarthasai Kattigal with RGM and the prognosis of the patient is calculated with, symptomatic improvement, reduction in size of fibroid and changes in pictorial blood assessment chart score from baseline visit to final visit and reduction in clinical symptoms of the patient by using uterine fibroid quality-of-life questionnaire, and the data were recorded. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
